Iron deficiency due to excessive therapeutic phlebotomy hemochromatosis

American Journal of Hematology

Volumn 65, Issue 3, 2000, Pages 223-226

  Barton, James C ^a,c   Bottomley, Sylvia S ^b  

^a SOUTHERN IRON DISORDERS CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Erythrocyte indices; Hemochromatosis; Iron; Iron deficiency; Therapeutic phlebotomy

Indexed keywords

FERROUS SULFATE; HEMOGLOBIN; IRON;

ADULT; ANEMIA; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL FEATURE; ESOPHAGUS VARICES; FEMALE; HEMOCHROMATOSIS; HEMOGLOBIN DETERMINATION; HUMAN; IRON DEFICIENCY; IRON THERAPY; MALE; MICROCYTOSIS; PHLEBOTOMY; PRIORITY JOURNAL; TOTAL HIP PROSTHESIS;

ADULT; AGED; ANEMIA, IRON-DEFICIENCY; ERYTHROCYTE INDICES; FEMALE; HEMOCHROMATOSIS; HUMAN; MALE; MIDDLE AGE; PHLEBOTOMY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0033792885     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8652(200011)65:3<223::AID-AJH8>3.0.CO;2-9     Document Type: Article

References (22)

1. Practice parameter for hereditary hemochromatosis
2. Peripheral blood erythrocyte parameters in hemochromatosis. Evidence for increased erythrocyte hemoglobin content
3. Genetic and clinical description of hemochromatosis probands and heterozygotes: Evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis
4. Disorders of iron metabolism: Iron deficiency and overload
5. A novel MHC class-I-like gene is mutated in patients with hereditary hemochromatosis
6. Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands
7. Cytochemistry of blood and marrow cells
8. Management of hemochromatosis: Hemochromatosis Management Working Group
9. The arthropathy of hemochromatosis
10. Abnormalities in estrogen, androgen and insulin metabolism in idiopathic hemochromatosis
11. Influence of phlebotomy treatment on abnormal hypothalamic-pituitary function in genetic hemochromatosis
12. Treatment of haemochromatosis by energetic phlebotomy; one patient's response to the letting of 55 litres of blood in 11 months
13. Twenty-four hour variation of transferrin saturation in treated and untreated haemochromatosis homozygotes
14. Hereditary hemochromatosis. Diagnosis in siblings and children
15. Value of the mean corpuscular volume as a guide to phlebotomy therapy in genetic hemochromatosis
16. Hereditary hemochromatosis in children, adolescents, and young adults
17. Clinical features of genetic hemochromatosis in women compared with men
18. Rate of iron re-accumulation following iron depletion in hereditary hemochromatosis. Implications for venesection therapy
19. Iron absorption in idiopathic haemochromatosis before, during, and after venesection therapy
20. Iron absorption in idiopathic haemochromatosis and its measurement using a whole-body counter
21. Patterns of food iron absorption in iron-deficient white and indian subjects and in venesected haemochromatosis patients
22. Ferrokinetics in man